We are live on ! Find out more
MCRB icon

Seres Therapeutics
MCRB

79 hedge funds and large institutions have $344M invested in Seres Therapeutics in 2017 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 29 increasing their positions, 25 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

283% more call options, than puts

Call options by funds: $1.14M | Put options by funds: $298K

16% more repeat investments, than reductions

Existing positions increased: 29 | Existing positions reduced: 25

12% more capital invested

Capital invested by funds: $308M → $344M (+$35.9M)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0.07% less ownership

Funds ownership: 3.85% → 3.78% (-0.07%)

11% less funds holding

Funds holding: 89 → 79 (-10)

18% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 11

Holders
79
Holders Change
-10
Holders Change %
-11.24%
% of All Funds
1.97%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
9
Increased
29
Reduced
25
Closed
11
Calls
$1.14M
Puts
$298K
Net Calls
+$843K
Net Calls Change
+$1.09M

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$17.2M
2
AIM
ARK Investment Management
Florida
+$1.4M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$1.05M
4
SIM
Spark Investment Management
New York
+$552K
5
JP Morgan Chase
JP Morgan Chase
New York
+$516K

Top Sellers

Rank Fund Capital Flow
1
Federated Hermes
Federated Hermes
Pennsylvania
-$3.2M
2
CC
CQS Cayman
Cayman Islands
-$1.6M
3
PCM
Portolan Capital Management
Massachusetts
-$1.1M
4
AG
Artal Group
Luxembourg
-$1.01M
5
Deutsche Bank
Deutsche Bank
Germany
-$967K
Name Holding Trade Value Shares
Change 		Change in
Stake
CG
51
Cutler Group
California
$171K +$2.03K +10 +1%
HLA
52
Hamilton Lane Advisors
Pennsylvania
$168K – – –
New York State Common Retirement Fund
53
New York State Common Retirement Fund
New York
$165K – – –
OPPM
54
Opus Point Partners Management
New York
$158K – – –
FRM
55
Fox Run Management
Connecticut
$136K +$123K +605 New
ARTA
56
A.R.T. Advisors
New York
$132K +$119K +588 New
CAN
57
Cetera Advisor Networks
California
$125K – – –
AIG
58
American International Group
New York
$124K +$7.31K +36 +7%
EMG
59
Ellington Management Group
Connecticut
$119K -$2.03K -10 -2%
NFA
60
Nationwide Fund Advisors
Ohio
$116K -$13K -64 -11%
Two Sigma Advisers
61
Two Sigma Advisers
New York
$115K +$2.03K +10 +2%
AG
62
Advisor Group
Arizona
$79K +$71K +350 New
UBS Group
63
UBS Group
Switzerland
$60K +$22.7K +112 +72%
Legal & General Group
64
Legal & General Group
United Kingdom
$59K – – –
PAM
65
Panagora Asset Management
Massachusetts
$59K +$8.73K +43 +20%
AIM
66
Acrospire Investment Management
Illinois
$50K -$33.5K -165 -42%
Acadian Asset Management
67
Acadian Asset Management
Massachusetts
$30K +$27K +133 New
AIP
68
Ameritas Investment Partners
Nebraska
$16K +$14K +69 New
SF
69
Synovus Financial
Georgia
$15K – – –
Royal Bank of Canada
70
Royal Bank of Canada
Ontario, Canada
$14K +$6.29K +31 +94%
MAM
71
Meeder Asset Management
Ohio
$13K -$8.12K -40 -40%
Zurich Cantonal Bank
72
Zurich Cantonal Bank
Switzerland
$12K – – –
Citigroup
73
Citigroup
New York
$11K -$67K -330 -87%
LTFS
74
Ladenburg Thalmann Financial Services
Florida
$10K – – –
SO
75
STRS Ohio
Ohio
$5K – – –
1 2
3
4

MCRB Hedge Fund Activity: Q1 2017 in Review

79 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Seres Therapeutics (MCRB) for Q1 2017, worth a combined $344M — up 12% from $308M a quarter earlier.

Sellers outnumbered buyers: 11 funds closed out of MCRB and 9 opened new positions — a net loss of 2 holders — while 25 trimmed existing stakes and 29 added.

The largest buyer was BlackRock, adding an estimated $17.2M. The largest seller was Federated Hermes, cutting an estimated $3.2M.

  • 79 institutional investors held Seres Therapeutics (MCRB) as of Q1 2017, down from 89 in Q4 2016.
  • Funds reported $344M of Seres Therapeutics stock for Q1 2017, up 12% quarter-over-quarter.
  • 9 funds opened new Seres Therapeutics positions in Q1 2017 and 11 closed out, a net change of -2 holders.
  • The largest Seres Therapeutics buyer in Q1 2017 was BlackRock, an estimated $17.2M added.
  • The largest Seres Therapeutics seller in Q1 2017 was Federated Hermes, an estimated $3.2M sold.

Based on aggregated 13F filings for Q1 2017.